Laird Norton Wetherby Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.5M | Sell |
15,949
-171
| -1% | -$49.6K | 0.18% | 91 |
|
|
2025
Q2 | $4.5M | Buy |
+16,120
| New | +$4.57M | 0.2% | 86 |
|
|
2024
Q4 | $4.28M | Sell |
16,430
-1,268
| -7% | -$376K | 0.21% | 82 |
|
|
2024
Q3 | $5.7M | Buy |
17,698
+44
| +0.2% | +$14.4K | 0.26% | 63 |
|
|
2024
Q2 | $5.52M | Sell |
17,654
-323
| -2% | -$94.9K | 0.26% | 64 |
|
|
2024
Q1 | $5.11M | Sell |
17,977
-337
| -2% | -$98.6K | 0.24% | 69 |
|
|
2023
Q4 | $5.27M | Buy |
18,314
+391
| +2% | +$107K | 0.27% | 61 |
|
|
2023
Q3 | $4.82M | Buy |
17,923
+472
| +3% | +$118K | 0.27% | 66 |
|
|
2023
Q2 | $3.87M | Sell |
17,451
-1,679
| -9% | -$390K | 0.21% | 85 |
|
|
2023
Q1 | $4.62M | Buy |
19,130
+459
| +2% | +$113K | 0.27% | 64 |
|
|
2022
Q4 | $4.9M | Buy |
18,671
+286
| +2% | +$76.7K | 0.32% | 58 |
|
|
2022
Q3 | $4.14M | Sell |
18,385
-223
| -1% | -$54.1K | 0.29% | 60 |
|
|
2022
Q2 | $4.53M | Buy |
18,608
+1,352
| +8% | +$331K | 0.31% | 52 |
|
|
2022
Q1 | $4.17M | Buy |
17,256
+935
| +6% | +$215K | 0.24% | 72 |
|
|
2021
Q4 | $3.67M | Buy |
16,321
+543
| +3% | +$115K | 0.21% | 93 |
|
|
2021
Q3 | $3.35M | Sell |
15,778
-1,415
| -8% | -$326K | 0.21% | 93 |
|
|
2021
Q2 | $4.19M | Buy |
17,193
+1,841
| +12% | +$453K | 0.26% | 72 |
|
|
2021
Q1 | $3.82M | Sell |
15,352
-1,871
| -11% | -$446K | 0.29% | 63 |
|
|
2020
Q4 | $3.96M | Buy |
17,223
+1,054
| +7% | +$243K | 0.27% | 67 |
|
|
2020
Q3 | $4.11M | Sell |
16,169
-257
| -2% | -$63.7K | 0.37% | 50 |
|
|
2020
Q2 | $3.88M | Buy |
16,426
+1,044
| +7% | +$238K | 0.37% | 50 |
|
|
2020
Q1 | $3.12M | Buy |
15,382
+1,580
| +11% | +$345K | 0.35% | 60 |
|
|
2019
Q4 | $3.33M | Sell |
13,802
-1,145
| -8% | -$252K | 0.33% | 67 |
|
|
2019
Q3 | $2.89M | Buy |
14,947
+822
| +6% | +$158K | 0.3% | 73 |
|
|
2019
Q2 | $2.6M | Sell |
14,125
-249
| -2% | -$44.6K | 0.28% | 78 |
|
|
2019
Q1 | $2.73M | Sell |
14,374
-553
| -4% | -$106K | 0.34% | 62 |
|
|
2018
Q4 | $2.91M | Buy |
14,927
+9
| +0.1% | +$1.76K | 0.41% | 51 |
|
|
2018
Q3 | $3.09M | Buy |
14,918
+347
| +2% | +$68.4K | 0.38% | 54 |
|
|
2018
Q2 | $2.69M | Sell |
14,571
-413
| -3% | -$73.1K | 0.36% | 59 |
|
|
2018
Q1 | $2.55M | Buy |
14,984
+269
| +2% | +$49.4K | 0.35% | 61 |
|
|
2017
Q4 | $2.56M | Buy |
14,715
+621
| +4% | +$110K | 0.36% | 59 |
|
|
2017
Q3 | $2.63M | Buy |
14,094
+233
| +2% | +$41.3K | 0.39% | 55 |
|
|
2017
Q2 | $2.39M | Buy |
13,861
+835
| +6% | +$136K | 0.41% | 47 |
|
|
2017
Q1 | $2.14M | Buy |
13,026
+512
| +4% | +$85.1K | 0.38% | 50 |
|
|
2016
Q4 | $1.83M | Sell |
12,514
-1,240
| -9% | -$187K | 0.36% | 55 |
|
|
2016
Q3 | $2.29M | Buy |
13,754
+1,048
| +8% | +$177K | 0.46% | 42 |
|
|
2016
Q2 | $1.93M | Buy |
12,706
+305
| +2% | +$47.4K | 0.43% | 49 |
|
|
2016
Q1 | $1.86M | Sell |
12,401
-586
| -5% | -$87.1K | 0.44% | 46 |
|
|
2015
Q4 | $2.11M | Sell |
12,987
-1,083
| -8% | -$170K | 0.51% | 40 |
|
|
2015
Q3 | $1.95M | Buy |
14,070
+812
| +6% | +$128K | 0.5% | 45 |
|
|
2015
Q2 | $2.04M | Buy |
13,258
+1,303
| +11% | +$209K | 0.49% | 38 |
|
|
2015
Q1 | $1.91M | Sell |
11,955
-482
| -4% | -$75.9K | 0.47% | 40 |
|
|
2014
Q4 | $1.98M | Buy |
12,437
+1,518
| +14% | +$237K | 0.5% | 34 |
|
|
2014
Q3 | $1.53M | Buy |
10,919
+51
| +0.5% | +$6.66K | 0.43% | 48 |
|
|
2014
Q2 | $1.29M | Sell |
10,868
-496
| -4% | -$57.4K | 0.36% | 57 |
|
|
2014
Q1 | $1.4M | Buy |
11,364
+18
| +0.2% | +$2.18K | 0.4% | 49 |
|
|
2013
Q4 | $1.29M | Buy |
11,346
+97
| +0.9% | +$11K | 0.37% | 57 |
|
|
2013
Q3 | $1.26M | Sell |
11,249
-690
| -6% | -$74.8K | 0.39% | 52 |
|
|
2013
Q2 | $1.18M | Buy |
+11,939
| New | +$1.24M | 0.41% | 47 |
|
Other funds holding AMGN
Laird Norton Wetherby Wealth Management's AMGN Position: Q3 2025 in Review
Laird Norton Wetherby Wealth Management reduced its Amgen (AMGN) stake by 1.1% in Q3 2025, selling an estimated $49.6K and leaving 15,949 shares worth $4.5M. The position accounts for 0.18% of the portfolio, ranked #91.
Laird Norton Wetherby Wealth Management first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $5.7M in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Laird Norton Wetherby Wealth Management held 15,949 shares of Amgen worth $4.5M as of Q3 2025.
- Laird Norton Wetherby Wealth Management sold 171 Amgen shares in Q3 2025, an estimated $49.6K.
- Amgen made up 0.18% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #91 holding.
- Laird Norton Wetherby Wealth Management first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
- Laird Norton Wetherby Wealth Management's Amgen position peaked at $5.7M in Q3 2024.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.